Fernández Fernández A, Maganto Pavón E, Vallejo Herrador J, Escudero Barrilero A
Servico de Urología del Hospital Ramón y Cajal de Madrid.
Actas Urol Esp. 1990 Jan-Feb;14(1):18-22.
Primary vesical adenocarcinoma is an extremely uncommon tumour, representing 0.5 to 2% of all the urothelial vesical neoplasias. Its behaviour is aggressive and its prognosis poor, especially in the seal ring cell variety. We present our experience in seven cases of vesical adenocarcinoma: one of urachal origin, two of the seal ring cell type, and four of the urothelial type with no other specificity. All were advanced stage tumours at diagnosis. There is no unified therapeutic strategy, and poor results were obtained with the various treatments used. Survival eight months after diagnosis was 42.8%. Longest survival is 15 months, corresponding to the adenocarcinoma of urachal origin.
原发性膀胱腺癌是一种极为罕见的肿瘤,占所有膀胱尿路上皮肿瘤的0.5%至2%。其生物学行为具有侵袭性,预后较差,尤其是印戒细胞型。我们介绍7例膀胱腺癌的诊治经验:1例脐尿管起源,2例印戒细胞型,4例尿路上皮型且无其他特殊情况。所有病例诊断时均为晚期肿瘤。目前尚无统一的治疗策略,采用的各种治疗方法效果不佳。诊断后8个月的生存率为42.8%。最长生存期为15个月,为脐尿管起源的腺癌。